|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/165 | (2006.01) |
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 1381356 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02763962.4 |
| Date of filing the European patent application | 2002-04-04 | |
| (97) | Date of publication of the European application | 2004-01-21 |
| (45) | Date of publication and mention of the grant of the patent | 2008-05-28 |
| (46) | Date of publication of the claims translation | 2008-09-25 |
| (86) | Number | PCT/US2002/010773 |
| Date | 2002-04-04 |
| (87) | Number | WO 2002/080897 |
| Date | 2002-10-17 |
| (30) | Number | Date | Country code |
| 281685 P | 2001-04-05 | US | |
| 0123571 | 2001-10-02 | GB |
| (72) |
WETTSTEIN, Joseph, US
|
| (73) |
Aventisub LLC,
3711 Kennett Pike, Suite 200, Greenville, Delaware, 19807,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | (Z)-2-ciano-3-hidroksi-but-2-eno rūgšties-(4'-trifluormetilfenil)-amido panaudojimas išsėtinės sklerozės gydymui |
| USE OF (Z)-2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID-(4`-TRIFLUOROMETHYLPHENYL)-AMIDE FOR TREATING MULTIPLE SCLEROSIS |
| Payment date | Validity (years) | Amount | |
| 2021-03-16 | 347.00 EUR |